Disposable Syringes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Conventional Syringes, Safety Syringes), By End Use (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 11.61 Billion
CAGR (2026-2031)	4.54%
Fastest Growing Segment	Conventional Syringes
Largest Market	North America
Market Size (2031)	USD 15.15 Billion

Market Overview

The Global Disposable Syringes Market is projected to grow from USD 11.61 Billion in 2025 to USD 15.15 Billion by 2031 at a 4.54% CAGR. Disposable syringes are single-use medical devices comprising a barrel, plunger, and needle, designed for injecting or aspirating fluids. The global market for these essential medical tools is primarily driven by the increasing prevalence of chronic diseases, which necessitate frequent parenteral drug administration, alongside expanding global vaccination programs aimed at controlling infectious diseases. Furthermore, a growing emphasis on infection control and patient safety in healthcare settings, particularly concerning the prevention of needlestick injuries and cross-contamination, fuels the demand for safety-engineered disposable syringes. According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, 11.1% of adults, or 1 in 9 individuals (aged 20-79), are living with diabetes, underscoring a significant global demand for injection devices for insulin therapy.

A substantial challenge impeding market expansion involves the stringent regulatory landscape across various regions. This complex regulatory environment mandates extensive product testing and approval processes, which can increase development costs and extend time-to-market for new or enhanced disposable syringe technologies. Moreover, managing the vast volumes of medical waste generated by single-use devices poses an ongoing environmental and logistical concern for healthcare systems worldwide.

Key Market Drivers

The increasing prevalence of chronic and infectious diseases significantly propels the global disposable syringes market. Conditions such as diabetes, autoimmune disorders, and various infectious diseases necessitate frequent administration of injectable medications, vaccines, or diagnostic agents. For instance, according to UNAIDS, in 2024, 1.3 million people became newly infected with HIV globally, requiring ongoing monitoring and treatment that often involves injectable therapies, thereby sustaining demand for syringes. The ongoing global health challenges continuously underscore the critical role of disposable syringes in both acute and long-term patient care, driving consistent market growth.

Another substantial driver is the expansion of global vaccination and immunization programs. These widespread public health initiatives, aimed at controlling infectious diseases like measles, polio, and influenza, rely heavily on the efficient and safe delivery of vaccines via disposable syringes. According to Gavi, the Vaccine Alliance, in 2024, Gavi-supported countries immunised more than 72 million unique children through routine immunisation programs, demonstrating the immense volume of syringes required for such campaigns. This systematic and large-scale demand for syringes, coupled with pharmaceutical advancements leading to new injectable drug therapies and biologics, underpins the market's trajectory. Furthermore, according to BD, for the full fiscal year ending September 30, 2025, the company reported a total revenue of $21.8 billion, highlighting the considerable scale of major medical technology providers contributing to the market.

Download Free Sample Report

Key Market Challenges

The stringent regulatory landscape across various regions presents a significant impediment to the growth of the global disposable syringes market. This complex environment mandates extensive product testing and approval processes, which directly increases development costs and prolongs the time required to bring new or enhanced disposable syringe technologies to market. Such rigorous requirements necessitate substantial investment in regulatory compliance and comprehensive documentation, diverting resources that could otherwise be allocated to innovation and market expansion.

This regulatory burden directly hampers market expansion through tangible financial and operational strains. According to MedTech Europe, in 2024, certification and maintenance costs for medical devices, including disposable syringes, escalated by up to 100% or more compared to previous directives, significantly impacting manufacturers' profitability and investment capacity. Furthermore, a 2025 MedTech Europe survey indicated a roughly 33% reduction in the selection of the EU as a first launch market for large device makers, underscoring how regulatory hurdles deter timely product introduction. The extended approval timelines, with most Medical Device Regulation (MDR) submissions taking approximately 13 to 18 months for 60% of cases from application to final certificate as of mid-2025, further delay patient access to essential injection devices.

Key Market Trends

The expanding utilization of pre-filled syringes represents a significant trend, driven by their inherent advantages in enhancing patient safety, ensuring accurate dosing, and improving convenience for both healthcare providers and patients engaged in self-administration. These ready-to-use devices minimize preparation steps, thereby reducing the potential for medication errors and contamination risks, particularly critical for sensitive biologics and vaccines. This technological shift supports the growing demand for user-friendly drug delivery systems within various therapeutic areas. For instance, according to BD, a global medical technology company, in January 2026, the company announced a $110 million investment to expand its production of prefillable syringes in the U.S., specifically to accelerate biologic and GLP-1 drug delivery and strengthen pharmaceutical supply chains. This investment underscores the industry's commitment to scaling up manufacturing capabilities for these advanced delivery systems to meet rising global demand.

Concurrently, a growing emphasis on sustainable syringe materials is shaping the market, propelled by increasing environmental consciousness and regulatory pressures to reduce medical waste. This trend involves the exploration and adoption of eco-friendlier alternatives, such as bio-based plastics and recyclable polymers, for both the syringes themselves and their associated packaging. Manufacturers are striving to innovate materials that maintain stringent safety and sterility requirements while minimizing their environmental footprint. An example of this broader industry shift is seen in packaging redesigns: according to DuPont's Tyvek® Sustainable Healthcare Packaging Awards announcement in October 2025, B. Braun redesigned its regional anesthesia and procedure tray packaging to eliminate 64 metric tons of plastic and 4,400 pounds of paper annually. This initiative highlights the active pursuit of material solutions across medical device components to achieve greater circularity in healthcare.

Segmental Insights

The Global Disposable Syringes Market features Conventional Syringes as a pivotal and rapidly expanding segment, largely driven by their significant cost advantage and widespread availability across diverse healthcare settings globally. These syringes serve as the default option in numerous government tenders and public health programs, particularly within price-sensitive and emerging markets where budget considerations often take precedence over safety-driven upgrades. Their deeply entrenched usage in routine therapeutic injections and extensive adoption for general medical procedures, including blood extractions, consistently fuels their substantial growth and dominant market share. The reliability and safety of these essential medical devices are guided by the robust regulatory frameworks established by institutions such as the U.S. Food and Drug Administration (FDA).

Regional Insights

North America holds a dominant position in the global disposable syringes market, primarily attributed to its highly developed healthcare infrastructure, particularly in countries like the United States and Canada. This region benefits from stringent regulatory frameworks, such as those implemented by the Food and Drug Administration, which mandate the adoption of single-use and safety-engineered syringes to ensure patient safety and effectively prevent cross-contamination. Moreover, the substantial prevalence of chronic diseases requiring frequent injectable therapies, alongside widespread vaccination initiatives, consistently drives strong demand for disposable syringes across various clinical settings.

Recent Developments

• In January 2026, Terumo Medical Corporation, a subsidiary of Terumo Corporation, introduced its SurTract™ Safety Syringe in the United States. This new product, developed in collaboration with Roncadelle Operations S.r.l. and powered by their SafeR® passive safety technology, entered distribution in hospitals, clinics, and emergency care settings during the first quarter of 2026. The SurTract Syringe features an automatic retraction mechanism that withdraws the needle into the plunger immediately after use, a design intended to reduce the risk of needle-stick injuries for healthcare professionals and enhance patient safety during injections. The system aims to provide a reliable and easy-to-use solution while maintaining standard clinical techniques.
• In January 2026, BD (Becton, Dickinson and Company) announced a significant investment of $110 million to expand its prefillable syringe production capabilities in the U.S.. This strategic investment aims to bolster the pharmaceutical supply chain and accelerate the delivery of biologic and glucagon-like peptide-1 (GLP-1) drugs. Specifically, $100 million was allocated to establish new BD Neopak™ Glass Prefillable Syringe production lines at its facility in Columbus, Nebraska, with supply targeted to commence by mid-2026. An additional $10 million was designated to enhance cannula manufacturing operations at the same site, contributing to approximately 120 new jobs.
• In April 2025, Gerresheimer, an established provider of pharmaceutical packaging and drug delivery systems, announced the launch of new silicone-oil- and PFAS-free ready-to-fill syringe systems. This initiative, stemming from an extended cooperation and supply and license agreement with Injecto Group A/S, addresses the increasing demand for advanced, contamination-free drug delivery solutions in the global disposable syringes market. The new systems, available in both glass and cyclic olefin polymer (COP), are particularly suited for sensitive biologics and specialized applications like ophthalmology, where minimizing particle load is critical. This collaboration secures the long-term availability of Injecto's patented plunger stoppers for Gerresheimer’s innovative syringe offerings.
• In January 2025, SCHOTT Pharma launched its next-generation SCHOTT TOPPAC® infuse polymer syringe system, marking a significant development for the global disposable syringes market. This innovative system, designed in collaboration with Alliance to Zero partners Schreiner MediPharm and Körber Pharma, aims to enhance safety, efficiency, and sustainability within healthcare. The new design features a pre-assembled cap for simplified pharmaceutical filling processes and an integrated functional label providing tamper evidence, oxygen protection, and potential for RFID tracking. Available in 3, 5, and 10ml volumes, this polymer syringe system addresses critical challenges such as medication waste and storage constraints in clinical environments.

Key Market Players

• Gerresheimer AG
• Baxter International Inc.
• Becton, Dickinson and Company
• B. Braun SE
• Cardinal Health, Inc.
• Schott AG
• Hindustan Syringes & Medical Devices Ltd
• Nipro Corporation
• Retractable Technologies Inc.
• Terumo Corporation

By Product	By End Use	By Region
Conventional Syringes Safety Syringes	Hospitals & Clinics Ambulatory Care Centers Diagnostic Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Disposable Syringes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Disposable Syringes Market, By Product:

• Conventional Syringes
• Safety Syringes

• Disposable Syringes Market, By End Use:

• Hospitals & Clinics
• Ambulatory Care Centers
• Diagnostic Centers
• Others

• Disposable Syringes Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE